KKKamal Khademvatani

Kamal Khademvatani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kamal Khademvatani has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Yousef Rezaei

    Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

    7 shared publications
  • Alireza Rostamzadeh

    Seyyed-al Shohada University Hospital, Urmia University of Medical Sciences, Urmia, Iran

    6 shared publications
  • Mir Hosein Seyyed Mohammadzad

    Department of Cardiology, Urmia University of Medical Sciences, Urmia, Iran

    5 shared publications
  • Mir Hossein Seyyed-Mohammadzad

    Department of Cardiology, Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences; Urmia-Iran.

    4 shared publications
  • Ramin Eskandari

    Department of Cardiology, Firoozgar Hospital, Iran University of Medial Sciences, Tehran, Iran

    4 shared publications
  • Abdollah Kerachian

    Department of Cardiology, Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences, Urmia, Iran

    2 shared publications

Latest Publications

  • Open Access

    Predicting the length of hospital stay in patients with congestive heart failure using data mining techniques

    by Mozhgan Esmaeili, Hadi Lotfnezhad Afshar, Bahlol Rahimi, Kamal Khademvatani, Shirin Samadzad Qushchi, Vahid Hoseinpour

    Introduction: Congestive heart failure (CHF) is a significant global challenge for healthcare systems, with its prevalence increasing due to an aging population. Accurate prediction of the length of stay (LOS) for CHF patients is critical for optimizing hospital resource management, reducing treatment costs, and improving the quality of medical care. This ...

  • Open Access

    FROM TREATMENT TO MENTAL HEALTH: INVESTIGATING THE RELATIONSHIP BETWEEN THERAPEUTIC APPROACHES IN MYOCARDIAL INFARCTION AND POST-MI DEPRESSION AND ANXIETY – A DESCRIPTIVE-CORRELATIONAL STUDY

    by Sorour Rahimi, Nima Sadeghzadeh, Yaser Moradi, Kamal Khadem Vatani

    Background & Aim: Myocardial infarction is one of the most common cardiovascular diseases, typically caused by thrombotic obstruction. The severity of myocardial damage and its outcomes can vary depending on the location and extent of coronary artery involvement. Consequently, this variability can lead to differing levels of depression and anxiety ...

  • Open Access

    COMPARISON OF THE EFFECTIVENESS OF ACUPRESSURE AND BENSON’S RELAXATION ON THE LEVEL OF ANXIETY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY

    by Nader Aghakhani, Pedram Abolfathpour, Kamal Khademvatan, Vahid Alinejad

    Background & Aim: Cardiovascular diseases are considered one of the most common causes of death worldwide. Given the increasing trend of heart diseases, one of the most common diagnostic and therapeutic methods that aid in the diagnosis and treatment of heart diseases is coronary angiography. Patients undergoing coronary angiography report ...


  • Open Access

    The predictive value of serum klotho in diabetes mellitus and hypertension

    by Kamal Khademvatani, Zahra Yekta, Mirhosein Seyed Mohammadzad, Shahriar Khanahmadi, Roghaiyeh Afsargharehbagh, Leila Majdi, Alireza Rostamzadeh, Mojgan Hajahmadipoor Rafsanjani, Ali Soleimany, Elham Niknejad, et al.

    Introduction: Klotho allele status is associated with increased risk of cardiovascular diseases, diabetes and hypertension. Objectives: To determine if serum klotho level was lower among diabetic and hypertensive patients compared to control group. Patients and Methods: This was a cross-sectional study of 90 participants. Thirty pure diabetic patients and 30 participants with pure hypertension were compared with the healthy control group. Multiple logistic regressions were used to examine the association between serum klotho and diabetes and hypertension. We also tested the cut off point of serum klotho to predict hypertension and diabetes by using ROC (receiver operating characteristic) curve. Results: The level of serum klotho was significantly lower in diabetic and hypertensive patients. Participants with higher klotho were less likely to have diabetes and hypertension [OR: 0.48, 95% CI (0.22-0.81)] even after adjustment for covariates. ROC curve for diabetes and hypertension indicated 0.8 area under the curve which was statistically significant. Conclusion: This study found that serum klotho was associated with lower odds of diabetes and hypertension. Further longitudinal studies are necessary to confirm this finding.


  • Open Access

    The Study of Acute Myocardial Infarctions Triggers in North-Western Iran

    by Kamal Khademvatani, Amin Sedokani, Sima Masudi, Parisa Nejati, Mir Hosein Seyyed Mohammadzad, Alireza Rahmani

    Background: Myocardial infarction (MI) is one of the important cardiovascular diseases. A trigger is an external stimulus, potential to create a pathological change leading to a clinical event. In addition to the risk factors of myocardial infarction, MI triggers play critical roles in the incidence of acute MI. Methods and Results: This is a cross-sectional study of patients with the first acute myocardial infarction in Seyedoshohada heart center of Urmia, Iran. 254 patients were enrolled in the study within one year of study. After 48 h of hospitalization, the patients were provided with the questionnaire to collecting the history of the disease ad triggers. Out of 220 (86.4%) patients with STEMI and 34 (13.6%) patients with NSTEMI, there were significant differences (p 2 . Conclusion: In addition to classic risk factors of myocardial infarction, health care systems must pay more attention to triggers that may induce an acute myocardial infarction in people with predisposing factors especially in the male sex, stressful and hand working jobs, and psychological and mental tension patients.

  • Open Access

    Echocardiographic and Laboratory Findings in Coronary Slow Flow Phenomenon: cross-sectional study and review

    by Mir Hosein Seyyed Mohammadzad, Salar Gardeshkhah, Kamal Khademvatani, Amin Sedokani

    Background and aims: Coronary Slow flow is a phenomenon known as slow contrast flow that injected into the coronary arteries, without epicardial coronary arteries obstruction. The etiology of this disease is unknown. Endothelial dysfunction, known as a major cause of Coronary Slow flow syndrome (CSF). Methods: This study was cross-sectional (descriptive-analytic), which was performed on patients admitted to Seyedoshohada Heart Center, during one year (2018-2019). Considering the inclusion and exclusion criteria, patients were divided into two groups of normal coronary arteries (NECA, as the control group) and with the Coronary slow-flow (CSF). Results: In the present study, 124 patients were studied, 67.9% in the coronary slow flow group and 39.4% in the control group were men (p=0.001). In the coronary slow flow group, the mean age of patients was 52.18 ± 12.55 years and in the control group, the mean age was 51.77 ± 10.36 years (p=0.18). Mean BMI was significantly higher in the coronary slow flow group than the control group (p <0.05). The smoking, hypertension, and mean of Lymphocyte, Hb, Hct, Plt, MPV, RDW, BUN, FBS, TG, TC, LDL was significantly higher coronary slow flow group. Also, in echocardiography, the mean E wave, E/A ratio was significantly lower in the coronary slow flow group. The GLS was also significantly lower in the control group (p=0.01). LAD was the most common type of coronaries that involved with a slow flow. Conclusion: The results of this study showed that there was a significant increase in the rate of coronary slow flow in men, smokers, high BMI, and hypertensive patients. Also, platelet count, MPV, LDL, FBS, and some laboratory variables were high in patients with CSF. Mild diastolic dysfunction and low GLS were observed in this group of patients.


  • Open Access

    Analysis of the mutations in exon 10 of MEFV gene in patients with premature coronary heart disease in west Azerbaijan province of Iran

    by Morteza Bagheri, Kamal Khadem-Vatani, Mir Hossein Seyed Mohammad Zad, Isa Abdi Rad, Behzad Rahimi, Alireza Rostamzadeh, Mojtaba Godarzi, Shabnam Ashena

    Introduction: Premature coronary heart disease (PCHD) affects public health and leads to death. PCHD has several genetic and environmental risk factors. The aim of this study was to analysis of the mutations in exon 10 of MEFV gene in patients with PCHD in West Azerbaijan province of Iran. Methods: Totally 41 PCHD patients who were admitted to the cardiology unit of Sayedoshohada hospital (Urmia, Iran) enrolled in the study. Selection of the patients was done based on the strict criteria, that is, who had a minimum of one angiographically documented coronary artery with the stenosis of 50%. Mutations in exon 10 of MEFV gene were found by direct sequencing. Results: V726A, M680I, K695R, and A744S mutations with 2.44%, 1.22%, 1.22%, and 1.22%, allelic frequency were found, respectively. Five patients (12.2%) with PCHD carried at least one mutated MEFV allele. Heterozygote V726A was the most frequent mutation among tested cases (4.88%), followed by heterozygote M680I, heterozygote K695R, and heterozygote A744S. Conclusion: The results of the present study imply that the frequency of the MEFV gene exon 10 is significantly high in PCHD patients. This is the first report in its own kind in clinically diagnosed PCHD pa­tients of Iranian Azeri Turkish population.


  • Study on a novel polymorphism in the VKORC1 promoter region using bioinformatic tools and warfarin dosing data

    by Behnam Askari, Esmat Khaleqsefat, Davood Khalafkhani, Mohammad Khalaj-Kondori, Kamal Khademvatan, Hamid Soraya


  • Open Access

    Short‐Term High‐Dose Vitamin E to Prevent Contrast Medium–Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo‐Controlled Trial

    by Yousef Rezaei, Kamal Khademvatani, Behzad Rahimi, Mehran Khoshfetrat, Nasim Arjmand, Mir‐Hossein Seyyed‐Mohammadzad

    Background: Contrast medium–induced acute kidney injury ( CIAKI ) is a leading cause of acquired renal impairment. The effects of antioxidants have been conflicting regarding the prevention of CIAKI . We performed a study of vitamin E use to decrease CIAKI in patients undergoing elective coronary angiography. Methods and Results: In a placebo‐controlled randomized trial at 2 centers in Iran, 300 patients with chronic kidney disease—defined as estimated glomerular filtration rate 2 —were randomized 1:1 to receive 0.9% saline infusion 12 hours prior to and after intervention combined with 600 mg vitamin E 12 hours before plus 400 mg vitamin E 2 hours before coronary angiography or to receive placebo. The primary end point was the development of CIAKI, defined as an increase ≥0.5 mg/dL or ≥25% in serum creatinine that peaked within 72 hours. Based on an intention‐to‐treat analysis, CIAKI developed in 10 (6.7%) and 21 (14.1%) patients in the vitamin E and placebo groups, respectively ( P =0.037). Change in white blood cell count from baseline to peak value was greater in the vitamin E group compared with the placebo group (−500 [−1500 to 200] versus 100 [−900 to 600]×10 3 /mL , P =0.001). In multivariate analysis, vitamin E (odds ratio 0.408, 95% CI 0.170–0.982, P =0.045) and baseline Mehran score (odds ratio 1.257, 95% CI 1.007–1.569; P =0.043) predicted CIAKI. Conclusions: Prophylactic short‐term high‐dose vitamin E combined with 0.9% saline infusion is superior to placebo for prevention of CIAKI in patients undergoing elective coronary angiography. Clinical Trial Registration: URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 02070679.


  • Open Access

    Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry

    by Hamid Reza Poorhoseini, Seyed Ebrahim Kassaian, Kianoosh Hoseini, Sepideh Saroukhani, Mojtaba Salarifar, Mohammad Alidoosti, Ebrahim Nematipour, Ali Mohammad Haji-Zeinali, Alireza Amirzadegan, Mir Hossein Seyyed Mohammadzadeh, et al.

    New-generation coronary stents including zotarolimus- and everolimus-eluting stents (ZES and EES) have been shown to decrease the risk of restenosis. The purpose of this study was to compare the safety and efficacy of ZES and EES over a 12-month clinical follow up, in routine clinical practice. This is an observational study in which 1029 consecutive patients treated with ZES (n = 669) or EES (n = 360) were enrolled. The study endpoint was major adverse cardiac events (MACE), defined as cardiac death, nonfatal myocardial infarction (MI), and target lesion or vessel revascularization at 12 months. Follow up was completed among 94.9% of the patients. The overall MACE occurred in 4 (0.6%) and 7 (2.0%) patients in the ZES and EES group, respectively. The occurrence of other cardiac events including nonfatal MI and target vessel or lesion revascularization was 1 (0.2%) versus 1 (0.3%) and 7 (1.1%) versus 5 (1.4%), respectively, in the ZES and EES groups of patients. Despite a slightly lower rate of MACE and cardiac death in the ZES group, the difference between these two groups was not significant (n = 0.064 for overall MACE, p = 0.129 for cardiac mortality, n = 0.999 for nonfatal MI, n = 0.468 for target vessel and n = 0.999 for target lesion revascularization). According to our results, it could be concluded that the difference in the rate of MACE between the ZES and EES groups was not statistically significant at 12-month follow up.